It’s not just about the conference sessions, our Congress recognises the importance of networking.
With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
The European Antibody Congress brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.
The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.
This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.
Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.
The agenda is being shaped by an industry advisory board, with members including:
Head of Oncology Programmes
Roche Pharmaceutical Research and Early Development
CSO and President
Reader, Antibody and Therapeutic Engineering
Queen Mary University of London
Senior Director, NBEs Analytical Chemistry, Pierre Fabre ; Associate Editor, mAbs
Scientific Director, Roche Pharma Research & Early Development
Roche Innovation Centre Munich
SVP & CSO, Research
Amgen Biologics Discovery
Global Head of Oncology Discovery
Executive Director, The Antibody Society ; Editor-in-Chief, mABs
Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, Neuroscience, and ADD
VP, Distinguished Research Fellow
AbbVie Abzena ADC Therapeutics Alligator Bioscience Amgen AstraZeneca Biogen Biosim Spanish Association of Biosimilars Boehringer Ingelheim Bristol Myers Squibb Cancer Research UK Cinfa Biotech GmbH Dr. Reddy's Laboratories SA. Duke University Medical Centre Eli Lilly & Co European Molecular Biology Laboratory European Patent Office European Specialist Nurses Organisations Ferrer International Fraunhofer IME Gedeon Richter Goldstein & Fox GSK HPAPI Project Services Ltd Janssen Libbs Pharmaceutica Lonza mAbs Macrogenics Maverick Therapeutics MedImmune Merck Merck, Sharp & Dohme (MSD) Napp pharmaceuticals NAPP Pharmaceuticals NBE Therapeutics NHS NIBR NICE NIHR Clinical Research Network (NIHR CRN) Norwegian Medicines Agency Novartis NovImmune NxR Biotechnologies Opsona Therapeutics Oril Industrie Ossianix PAREXEL Paul Ehrlich Institute Pfizer Biotherapeutics Pieris Pharmaceuticals Pierre Fabre Prima BioMed Roche Roche S.A.Toral SafeBridge Sandoz Biopharmaceuticals Sandoz Sanofi Sanofi R&D Sanquin Seattle Genetics Technische Universität Braunschweig Teva Pharmaceuticals The Royal Marsden NHS Foundation Trust Therapeomic TU Wien UCB Celltech University of Cambridge University of Denmark University of Messina – Italy University of Stuttgart
Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October